Patents by Inventor Katherine Schouest

Katherine Schouest has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9512493
    Abstract: Polynucleotides having a first polynucleotide segment contiguous with a second polynucleotide segment that is downstream to the first, wherein the sequence of the first polynucleotide segment is complementary to the sequence of a first probe segment of a probe for detection of a target nucleic acid sequence, wherein the sequence of the second polynucleotide segment is complementary to the sequence of a second probe segment of the probe, wherein the second probe segment is downstream to the first probe segment, are provided. The polynucleotides may be employed with dual-labeled probes (DLPs) in assays for the detection of the target nucleic acid sequences.
    Type: Grant
    Filed: July 31, 2012
    Date of Patent: December 6, 2016
    Assignee: Grifols Therapeutics Inc.
    Inventors: Danuta Wronska, Katherine Schouest
  • Patent number: 9273366
    Abstract: The present invention relates to compositions, methods, and kits for determining the presence or absence of HIV in a sample, in particular for determining HIV-1 group M, HIV-1 group O, and/or HIV-2, in particular for simultaneous determining of HIV-1 group M, HIV-1 group O, and HIV-2.
    Type: Grant
    Filed: June 14, 2012
    Date of Patent: March 1, 2016
    Assignee: Grifols Therapeutics Inc.
    Inventors: Danuta Wronska, Katherine Schouest, Leslie Tremlett
  • Publication number: 20140295408
    Abstract: Polynucleotides having a first polynucleotide segment contiguous with a second polynucleotide segment that is downstream to the first, wherein the sequence of the first polynucleotide segment is complementary to the sequence of a first probe segment of a probe for detection of a target nucleic acid sequence, wherein the sequence of the second polynucleotide segment is complementary to the sequence of a second probe segment of the probe, wherein the second probe segment is downstream to the first probe segment, are provided. The polynucleotides may be employed with dual-labeled probes (DLPs) in assays for the detection of the target nucleic acid sequences.
    Type: Application
    Filed: July 31, 2012
    Publication date: October 2, 2014
    Applicant: GRIFOLS THERAPEUTICS INC.
    Inventors: Danuta Wronska, Katherine Schouest
  • Publication number: 20140120526
    Abstract: The present invention relates to compositions, methods, and kits for determining the presence or absence of HIV in a sample, in particular for determining HIV-1 group M, HIV-1 group O, and/or HIV-2, in particular for simultaneous determining of HIV-1 group M, HIV-1 group O, and HIV-2.
    Type: Application
    Filed: June 14, 2012
    Publication date: May 1, 2014
    Applicant: GRIFOLS THERAPEUTICS INC.
    Inventors: Danuta Wronska, Katherine Schouest, Leslie Tremlett